Researchers at BHC, the University of Utah and Columbia University teamed up to publish our most recent paper, Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue...
Research News
Dr. Bateman’s Message About Education and Research
Successful people frequently say the key to success is showing up every day and putting in the work. After that it takes determination and patience, along with good timing, a little luck, and lots of help from others to meet lofty goals. At BHC, we embrace that...
Four New Clinical Trials in 2022
Many investigators pivoted to SARS-CoV-2 and COVID-19 science and medicine in 2020. We did too at BHC because we understood the opportunity the pandemic provided for "real-time" clinical research of post-COVID-19 sequelae and to share all we know about ME/CFS -...
Endothelial Dysfunction & Brain Fog
In the coming weeks, BHC will start a new research study that you may be eligible to participate in! This research will assess endothelial function and upright activity in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID, which is...
Long COVID RECOVER Initiative
The Researching COVID to Enhance Recovery (RECOVER), is an Initiative of the National Institutes of Health that aims to understand, prevent, and treat post-acute sequelae of SARS-CoV-2 (PASC), including Long COVID.
Improving Lives Today Begins with Education
Improving Lives Today Begins with Education. Regardless of age, education, or experience, learning is the catalyst for change. You cannot influence a process, mindset, or required skill without learning what needs improvement and how to accomplish it. That is why credentialed medical providers are required to refresh and expand their knowledge base. The advent […]
Dr. Bateman on Cortene and CT38
When Cortene contacted BHC with an idea, and an early draft protocol designed to test CT38 as a treatment for ME/CFS, Dr. Suzanne Vernon and I agreed to help them refine the protocol and conduct the trial. The Cortene-funded trial was an FDA and IRB-approved...
Cortene Weighs-In on Future Plans for CT38
Frontiers in Systems Neuroscience published the study results of Cortene Inc's investigational drug CT38 in people with ME/CFS. The trial was conducted at Bateman Horne Center and Suzanne Vernon, PhD, wrote a blog post providing context about the study. Cortene Inc....
Growing Seeds through Research
Incredible people have spent time at BHC as interns, pre-med students, and clinical research coordinators as a way point in their educational journeys. As a part of our mission, we hire and train upcoming researchers and medical professionals to help be a product of...
Unexpected Impact
Incredible people have spent time at BHC as interns, pre-med students, and clinical research coordinators as a way point in their educational journeys. As a part of our mission, we hire and train upcoming researchers and medical professionals to help be a product of...
The Unicorn Model
BHC: A Unique Clinical Research Center Of all of the places I’ve worked, BHC is the one with the greatest promise to improve the lives of those impacted by ME/CFS, FM and post-viral illnesses. Why? Because of our unique model of clinical care, research, and education....
Research: Validating Innovative Pathways
It's Research Week at Bateman Horne Center! This means that as part of our Mission Possible giving campaign we fill you in on why research is so important to our organization and how we are using it to improve the lives of those with ME/CFS, fibromyalgia, post-viral...